4
SARMs Steroids S4 Powder Andarine GTX-007 SARM Steroid CAS 401900-40-1 for Muscle Building
- Manufacturer: Dewael
- Product Assay: 99%+
- Appearance:white Crystalline powder.
- Place of Origin: China
- Certification: SGS,ISO9001,GMP
- Minimum Order Quantity: 10g
- Packaging Details: Discreet ways of packing for Customs pass guaranteed
- Delivery Time: Within 12 hours after receiving your payment
- Payment Terms: Western Union, MoneyGram,Bitcoin,Bank Transfer
- Shipping: EMS,DHL,Fedex,UPS,TNT and so on.
- Policy: Re-Shipping Policy
- Supply ability: 500-600kg/month
SARMs Steroids S4 Powder Andarine GTX-007 SARM Steroid CAS 401900-40-1 for Muscle Building
Quick Details:
| Product Name | S4 / Andarine |
| Synonym | GTx-007, S4 |
| CAS | 401900-40-1 |
| Assay | 99% |
| Packing | 1kg net/foil bag, 5kg/drum. |
| Standard | Enterprise Standard |
| Storage | Shading , Confined Preservation |
| Usage | For treatment of conditions such as muscle wasting, osteoporosis and benign prostatic hypertrophy |
| Molecular Fomular | C19H18F3N3O6 |
| Molecular Weight | 441.36 |
| MolecularStructure | ![]() |
Description
S4 / Andarine is an investigational selective androgen receptor modulator for treatment of conditions such as muscle wasting, osteoporosis and benign prostatic hypertrophy, using the non-steroidal androgen antagonist bicalutamide as a lead compound.
S4 / Andarine is an orally active partial agonist for androgen receptors. S4 / Andarine is less potent in both anabolic and androgenic effects than other SARMs.
S4 / Andarine was shown to reduce prostate weight with similar efficacy to finasteride in an animal model of benign prostatic hypertrophy, but without producing any reduction in muscle mass or anti-androgenic side effects. It suggests that S4 / Andarine is able to competitively block binding of dihydrotestosterone to its receptor targets in the prostate gland, but its partial agonist effects at androgen receptors prevent the side effects associated with the anti-androgenic drugs traditionally used for treatment of BPH.
Usage
Andarine (GTx-007, S-4) is an investigational selective androgen receptor modulator (SARM) developed by GTX, Inc for treatment of conditions such as muscle wasting, osteoporosis and benign prostatic hypertrophy, using the non-steroidal androgen antagonist bicalutamide as a lead compound.
Andarine is an orally active partial agonist for androgen receptors. It is less potent in both anabolic and androgenic effects than other SARMs. In an animal model of benign prostatic hypertrophy, andarine was shown to reduce prostate weight with similar efficacy to finasteride, but without producing any reduction in muscle mass or anti-androgenic side effects. This suggests that it is able to competitively block binding of dihydrotestosterone to its receptor targets in the prostate gland, but its partial agonist effects at androgen receptors prevent the side effects associated with the anti-androgenic drugs traditionally used for treatment of BPH.
Application
As said earlier, SARMS function by tying to the AR resulting to anabolic activity . Due to this fastening and stimulation, more protein is produced which allows muscle building. S4 can trigger muscle development in the same way as steroids, but minus the same unwanted side effects, the latter has on the prostate and other sexual organs .
How it’s used depends on what effects you’re looking after. Fat elimination or cutting is the most effective use for S4 Andarine .
Right Dosing.Recommended dose for cutting is 50 mg for 6-8 weeks. You should use it every day then take 2 days off for the duration. Taking S4 daily for the length of the cycle can lead to changes in eyesight.
How Andarine (S4) works?
All SARM work is done by combining with androgen receptors, resulting in anabolic activity. In addition, there is more protein synthesis that allows to create more muscle. These effects are similar to synthetic metabolic steroids. However, in the case of SARMS, there is no aromatization, liver stress, severe HPTA (hypothalamic pituitary testicular axis) inhibition and general side effects.
COA:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
Other Related SARMs:
| Name | CAS NO. | Usage |
| AICAR | 2627-69-2 | acts by entering nucleoside pools, significantly increasing levels of adenosine during periods of ATP breakdown |
| MK2866 | 841205-47-8 | medical prescription for prevention of cachexia, atrophy, and sarcopenia and for Hormone or Testoserone Replacement Therapy. |
| MK-677 | 15972-10-0 | A growth hormone secretagogue, treatment of obesity, a promising therapy for the treatment of frailty in the elderly |
| LGD-4033 | 1165910-22-4 | pharmacological profile similar to that of enobosarm, Ostarine,MK-2866 |
| GW501516 | 317318-70-0 | For obesity, diabetes, dyslipidemia and cardiovascular disease |
| Andarine(S4) | 401900-40-0 | partial agonist, intended mainly for treatment of benign prostatic hypertrophy |
| SR9009 | 1379686-30-2 | under development at The Scripps Research Institute (TSRI), increases the level of metabolic activity in skeletal muscles of mice |
| RAD140 | 1182367-47-0 | New generation for gaining mass and cutting edges |
| YK11 | 431579-34-9 | YK11: a SARM and myostatin inhibitor in on |
———————————————————————————————————————————————————————————————————————————————————————-
Contact Now

.jpg)




















Reviews
There are no reviews yet.